Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (441-450 of 567) with videos related to

Pageof 57
Sort By:
Circulation|January 11, 2000
Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockadeA M Lincoff, D B Mark, J E Tcheng, et al.
American Heart Journal|July 1, 1999
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)C M O'Connor, W A Gattis, B F Uretsky, et al.
Journal of the American College of Cardiology|June 1, 1995
Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT)R A Harrington, A M Lincoff, R M Califf, et al.
Circulation|May 1, 1994
Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplastyD B Mark, C L Nelson, R M Califf, et al.
The American Journal of Cardiology|August 11, 1992
Angiographic follow-up after internal mammary artery graft angioplastyM H Sketch, P J Quigley, J A Perez, et al.
Circulation|November 11, 1991
Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgeryL R Smith, F E Harrell, J S Rankin, et al.
Diabetes, Obesity & Metabolism|May 28, 2014
Change in levels of physical activity after diagnosis of type 2 diabetes: an observational analysis from the NAVIGATOR studyD Preiss, S M Haffner, L E Thomas, et al.
The American Journal of Cardiology|June 1, 1986
A simplified method to predict occurrence of complete heart block during acute myocardial infarctionG A Lamas, J E Muller, Z G Turi, et al.
The American Journal of Cardiology|December 15, 1996
Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesM Labinaz, M H Sketch, A L Stebbins, et al.
Circulation|November 11, 1992
Observational comparison of event-free survival with medical and surgical therapy in patients with coronary artery disease. 20 years of follow-upL H Muhlbaier, D B Pryor, J S Rankin, et al.
Pageof 57

Showing results (441-450 of 567) with videos related to

Sort By:
Pageof 57
Circulation|January 11, 2000
Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockadeA M Lincoff, D B Mark, J E Tcheng, et al.
American Heart Journal|July 1, 1999
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)C M O'Connor, W A Gattis, B F Uretsky, et al.
Journal of the American College of Cardiology|June 1, 1995
Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT)R A Harrington, A M Lincoff, R M Califf, et al.
Circulation|May 1, 1994
Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplastyD B Mark, C L Nelson, R M Califf, et al.
The American Journal of Cardiology|August 11, 1992
Angiographic follow-up after internal mammary artery graft angioplastyM H Sketch, P J Quigley, J A Perez, et al.
Circulation|November 11, 1991
Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgeryL R Smith, F E Harrell, J S Rankin, et al.
Diabetes, Obesity & Metabolism|May 28, 2014
Change in levels of physical activity after diagnosis of type 2 diabetes: an observational analysis from the NAVIGATOR studyD Preiss, S M Haffner, L E Thomas, et al.
The American Journal of Cardiology|June 1, 1986
A simplified method to predict occurrence of complete heart block during acute myocardial infarctionG A Lamas, J E Muller, Z G Turi, et al.
The American Journal of Cardiology|December 15, 1996
Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesM Labinaz, M H Sketch, A L Stebbins, et al.
Circulation|November 11, 1992
Observational comparison of event-free survival with medical and surgical therapy in patients with coronary artery disease. 20 years of follow-upL H Muhlbaier, D B Pryor, J S Rankin, et al.
Pageof 57